Results 261 to 266 of about 37,426,579 (266)

Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study.

Ca-A Cancer Journal for Clinicians
Yan Yu, Diansheng Zhong, Lin Wu
exaly  

Business models for open innovation: Matching heterogeneous open innovation strategies with business model dimensions

European Management Journal, 2015
Tina Saebi
exaly  

Reduced-volume radiotherapy versus conventional-volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open-label, noninferiority, multicenter, randomized phase 3 trial

Ca-A Cancer Journal for Clinicians
Yin Zhao, Wen-Fei Li, Na Liu
exaly  

Acceptance and use predictors of open data technologies: Drawing upon the unified theory of acceptance and use of technology

Government Information Quarterly, 2015
Marijn Janssen, Anneke Zuiderwijk, Yogesh Kumar Dwivedi   +2 more
exaly  

Open data policies, their implementation and impact: A framework for comparison

Government Information Quarterly, 2014
Marijn Janssen, Anneke Zuiderwijk
exaly  

Open-ST: High-resolution spatial transcriptomics in 3D

Cell
exaly